Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Asset Utilization Ratio (2020 - 2025)

Revolution Medicines (RVMD) has 6 years of Asset Utilization Ratio data on record, last reported at 0.0 in Q4 2025.

  • For Q4 2025, Asset Utilization Ratio changed N/A year-over-year to 0.0; the TTM value through Dec 2025 reached 0.0, changed N/A, while the annual FY2023 figure was 0.01, 82.35% down from the prior year.
  • Asset Utilization Ratio reached 0.0 in Q4 2025 per RVMD's latest filing, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.06 in Q1 2021 and bottomed at 0.0 in Q4 2025.
  • Average Asset Utilization Ratio over 5 years is 0.03, with a median of 0.04 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: grew 8.26% in 2022, then tumbled 1274.97% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.04 in 2021, then rose by 8.26% to 0.04 in 2022, then tumbled by 82.4% to 0.01 in 2023, then crashed by 94.54% to 0.0 in 2024, then tumbled by 1294.11% to 0.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.0 in Q4 2025, 0.0 in Q3 2025, and 0.0 in Q3 2024.